3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
6
Colonic Neoplasms
4
Rectal Neoplasms
3
Pancreatic Adenocarcinoma
3
Squamous Cell Carcinoma of Head and Neck
2
Colorectal Neoplasms
2
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Tongue Neoplasms
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7
1
Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7
1
Somatostatinoma
1
Salivary Gland Neoplasms
1
Pancreatic Intraductal Neoplasms
1
PRETEXT I Hepatoblastoma
1
Oropharyngeal Neoplasms
1
Lymphoid Interstitial Pneumonia
1
Klatskin Tumor
1
Gastrointestinal Neoplasms
1
Gallbladder Neoplasms
1
Esophageal Neoplasms
1
DNA Repair-Deficiency Disorders
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Cholangiocarcinoma
1
Carcinoma, Hepatocellular
1
Bile Duct Neoplasms
1
Anus Neoplasms
1
Interventions
fludarabine phosphate
32
Peripheral Blood Stem Cell Transplantation
27
Tacrolimus
26
Cyclophosphamide
26
Whole-Body Irradiation
25
Busulfan
21
Mycophenolic Acid
20
Methotrexate
16
Antilymphocyte Serum
16
Melphalan
12
Cyclosporine
9
Cord Blood Stem Cell Transplantation
8
Filgrastim
7
Etoposide
7
Thiotepa
6
thymoglobulin
5
merphos
5
Sirolimus
5
Rituximab
5
Radiotherapy
5
Methylprednisolone
5
Cytarabine
5
Granulocyte Colony-Stimulating Factor
4
sargramostim
3
fludarabine
3
Flow Cytometry
3
Transplantation
2
Polymerase Chain Reaction
2
Ondansetron
2
Imatinib Mesylate
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Myeloid, Accelerated Phase
×
dehydroftorafur
×
Clear all
No trials found.